41 related articles for article (PubMed ID: 12839566)
1. Lack of Type 2 Innate Lymphoid Cells Promotes a Type I-Driven Enhanced Immune Response in Contact Hypersensitivity.
Rafei-Shamsabadi DA; van de Poel S; Dorn B; Kunz S; Martin SF; Klose CSN; Arnold SJ; Tanriver Y; Ebert K; Diefenbach A; Halim TYF; McKenzie ANJ; Jakob T
J Invest Dermatol; 2018 Sep; 138(9):1962-1972. PubMed ID: 29526762
[TBL] [Abstract][Full Text] [Related]
2. Targeted Delivery of Immunomodulators to Lymph Nodes.
Azzi J; Yin Q; Uehara M; Ohori S; Tang L; Cai K; Ichimura T; McGrath M; Maarouf O; Kefaloyianni E; Loughhead S; Petr J; Sun Q; Kwon M; Tullius S; von Andrian UH; Cheng J; Abdi R
Cell Rep; 2016 May; 15(6):1202-13. PubMed ID: 27134176
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic-Dependent Modulation of the Sensitization and Elicitation Phases of Contact Hypersensitivity.
Aradi P; Kovács G; Kemecsei É; Molnár K; Sági SM; Horváth Z; Mehrara BJ; Kataru RP; Jakus Z
J Invest Dermatol; 2024 Mar; ():. PubMed ID: 38548256
[TBL] [Abstract][Full Text] [Related]
4. GPR91 deficiency exacerbates allergic contact dermatitis while reducing arthritic disease in mice.
Rubić-Schneider T; Carballido-Perrig N; Regairaz C; Raad L; Jost S; Rauld C; Christen B; Wieczorek G; Kreutzer R; Dawson J; Lametschwandner G; Littlewood-Evans A; Carballido JM
Allergy; 2017 Mar; 72(3):444-452. PubMed ID: 27527650
[TBL] [Abstract][Full Text] [Related]
5. Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG.
Brasch J; Becker D; Aberer W; Bircher A; Kränke B; Jung K; Przybilla B; Biedermann T; Werfel T; John SM; Elsner P; Diepgen T; Trautmann A; Merk HF; Fuchs T; Schnuch A
Allergo J Int; 2014; 23(4):126-138. PubMed ID: 26146602
[No Abstract] [Full Text] [Related]
6. Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.
Orlow SJ
Paediatr Drugs; 2007; 9(5):289-99. PubMed ID: 17927301
[TBL] [Abstract][Full Text] [Related]
7. Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.
Azam P; Sankaranarayanan A; Homerick D; Griffey S; Wulff H
J Invest Dermatol; 2007 Jun; 127(6):1419-29. PubMed ID: 17273162
[TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids.
Kalthoff FS; Chung J; Musser P; Stuetz A
Clin Exp Immunol; 2003 Sep; 133(3):350-9. PubMed ID: 12930360
[TBL] [Abstract][Full Text] [Related]
9. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
Grassberger M; Steinhoff M; Schneider D; Luger TA
Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
[TBL] [Abstract][Full Text] [Related]
10. Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A.
Meingassner JG; Fahrngruber H; Bavandi A
J Invest Dermatol; 2003 Jul; 121(1):77-80. PubMed ID: 12839566
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity.
Bavandi A; Fahrngruber H; Aschauer H; Hartmann B; Meingassner JG; Kalthoff FS
J Dermatol Sci; 2006 Aug; 43(2):117-26. PubMed ID: 16806841
[TBL] [Abstract][Full Text] [Related]
12. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
[TBL] [Abstract][Full Text] [Related]
13. [Development and pre-clinical aspects of pimecrolimus].
Stütz A; Grassberger M; Meingassner JG
Hautarzt; 2003 May; 54(5):405-12. PubMed ID: 12719859
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.
Stuetz A; Grassberger M; Meingassner JG
Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
